Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Finasteride helps hair growth but may cause sexual side effects and depression.

Patients with Alopecia Areata are willing to trade life duration for better quality of life.

Finasteride for hair loss may cause depression, affecting sleep and relationships.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Spironolactone might cause painful intercourse and decreased sexual arousal in women.

Spironolactone may cause sexual pain and arousal issues in women, which can improve after stopping the drug and using hormone cream.

Continuous glucose monitoring and GLP-1 receptor agonists improve diabetes management, but personalized care and education are crucial.

Isotretinoin treatment in Palestine shows poor adherence to guidelines, with common side effects and a need for better prescribing practices and patient education.

5-alpha reductase inhibitors do not increase osteoporosis risk in women with certain hair loss conditions.

Systemic minoxidil is generally safe for older adults, but caution is needed for those with heart risks.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

A 2-year-old boy grew excessive hair after using minoxidil for hair loss, but it improved when the treatment stopped.

Avacopan may cause unexpected side effects, so early monitoring is important.

Some common medications may harm male fertility by affecting hormones, sperm production, and sexual function.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Anticoagulant therapy may cause hair loss, especially in women, and stopping the medication can lead to hair regrowth.

Food intake, not genetics, affects how the body processes tadalafil and finasteride.

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

The document lists various dermatology topics, treatments, and diagnostic methods.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

Oral spironolactone's effectiveness for adult female acne is not well-supported by strong evidence.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Minoxidil effectively treats hair loss, especially androgenetic alopecia, but needs more research for better understanding.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

A new diagnostic tool for Vulvovaginal Lichen Planus is highly accurate, and updated treatments for various skin conditions, including melanoma and Hidradenitis Suppurativa, were discussed.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.